TY  - JOUR
AU  - Carcel-Marquez, Jara
AU  - Cullell, Natalia
AU  - Muiño, Elena
AU  - Gallego-Fabrega, Cristina
AU  - Lledos, Miquel
AU  - Ibañez, Laura
AU  - Krupinski, Jerzy
AU  - Montaner, Joan
AU  - Cruchaga, Carlos
AU  - Lee, Jin-Moo
AU  - Gill, Dipender
AU  - Pare, Guillaume
AU  - Mola-Caminal, Marina
AU  - Roquer, Jaume
AU  - Jimenez-Conde, Jordi
AU  - Marti-Fabregas, Joan
AU  - Fernandez-Cadenas, Israel
PY  - 2021
DO  - 10.1161/STROKEAHA.120.033041
UR  - http://hdl.handle.net/10668/17637
T2  - Stroke
AB  - MMP (matrix metalloproteinase) levels have been widely associated with ischemic stroke risk and poststroke outcome. However, their role as a risk factor or as a subeffect because of ischemia is uncertain. We performed a literature search of...
LA  - en
PB  - Lippincott Williams & Wilkins
KW  - atherosclerosis
KW  - ischemic stroke
KW  - metalloproteinase
KW  - modified Rankin Scale
KW  - risk factor
KW  - Biomarkers
KW  - Cohort Studies
KW  - Female
KW  - Genome-Wide Association Study
KW  - Humans
KW  - Ischemic Stroke
KW  - Male
KW  - Matrix Metalloproteinase 1
KW  - Matrix Metalloproteinase 12
KW  - Matrix Metalloproteinase 8
KW  - Mendelian Randomization Analysis
TI  - Causal Effect of MMP-1 (Matrix Metalloproteinase-1), MMP-8, and MMP-12 Levels on Ischemic Stroke: A Mendelian Randomization Study.
TY  - research article
VL  - 52
ER  -